WO2005107783A1 - Food containing extract from bark of pine - Google Patents

Food containing extract from bark of pine Download PDF

Info

Publication number
WO2005107783A1
WO2005107783A1 PCT/JP2005/006540 JP2005006540W WO2005107783A1 WO 2005107783 A1 WO2005107783 A1 WO 2005107783A1 JP 2005006540 W JP2005006540 W JP 2005006540W WO 2005107783 A1 WO2005107783 A1 WO 2005107783A1
Authority
WO
WIPO (PCT)
Prior art keywords
pine bark
bark extract
body fat
mass
pine
Prior art date
Application number
PCT/JP2005/006540
Other languages
French (fr)
Japanese (ja)
Inventor
Kinya Takagaki
Original Assignee
Toyo Shinyaku Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Shinyaku Co., Ltd. filed Critical Toyo Shinyaku Co., Ltd.
Publication of WO2005107783A1 publication Critical patent/WO2005107783A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Definitions

  • the present invention relates to a body fat accumulation inhibitor or a body fat reducing agent containing a pine bark extract and soy beptide. More specifically, the present invention relates to a food containing a pine bark extract and a soybean peptide.
  • the present inventors have intensively studied a combination of components having an effect of suppressing or reducing the accumulation of body fat. As a result, they have found that by preparing a food containing a soybean peptide and a pine bark extract, an excellent effect of suppressing or reducing the accumulation of body fat can be obtained, leading to the present invention.
  • the present invention relates to a body fat accumulation inhibitor or a body fat reducing agent containing a pine peel extract and a soybean peptide.
  • the present invention also relates to a food containing a pine bark extract and a soy peptide.
  • a body fat accumulation inhibitor or a body fat reducer containing a pine bark extract and soy beptide exhibits an excellent body fat accumulation inhibitory or reducing effect by combining them.
  • OPC in the pine bark extract is likely to be absorbed into the body, and promotes the excretion of cholesterol and the decomposition of neutral fats in the body, which is considered to have the effect of efficiently metabolizing fats.
  • a food containing a pine bark extract and a soy peptide is a food excellent in palatability because the soy peptide reduces the characteristic flavor of the pine bark extract.
  • the pine bark used as the raw material for the pine bark extract is French pine (Pinus Mart ima), larch, Japanese black pine, Japanese pine, Japanese pine, Japanese pine, and butterfly.
  • the bark of a plant belonging to the order Pinaceae such as Satsumamatsu, Himatsu, Ryukyuenmatsu, Pakshimatsu, Daiomatsu, Shiguchimatsu, and Aneda in Quebec, Canada is preferably used.
  • bark of French pine (Pinus Martima) is preferably used.
  • French pine is a marine pine that grows on part of the Atlantic coast of southern France.
  • the skin of this French shore pine contains proanthocyanidins, organic acids, and other bioactive ingredients.
  • the pine bark extract used in the present invention is obtained by extracting the pine bark with water or an organic solvent. If water is used, hot or hot water is used.
  • an organic solvent a solvent acceptable for the production of foods or drugs can be used. Examples of such an organic solvent include methanol, ethanol, 1-prono-nore, 2-prono-nore, 1-ptano-nore, 2-butanol, acetone, hexane, hexane, hexane, propylene glycol, and hydrous alcohol.
  • These water and organic solvent may be used alone or in combination of two or more.
  • water, ethanol, aqueous ethanol, and aqueous propylene dalicol are preferably used. From the viewpoint of safety when used for foods or pharmaceuticals, water, ethanol, and hydrous ethanol are more preferable, and it is more preferable to extract by heating.
  • the extraction method from the pine bark there is no particular limitation on the extraction method from the pine bark, and for example, a heating extraction method, a supercritical fluid extraction method, or the like is used.
  • Supercritical fluid extraction is a method in which a substance is extracted using a supercritical fluid, which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of gas-liquid.
  • Supercritical fluids include carbon dioxide, ethylene, propane, nitrous oxide (laughing gas), etc. And diacid carbon is preferably used.
  • the supercritical fluid extraction method includes an extraction step of extracting a target component with a supercritical fluid, and a separation step of separating the target component from the supercritical fluid.
  • a separation step any of extraction separation by pressure change, extraction separation by temperature change, and extraction separation using an adsorbent / absorbent may be performed.
  • a supercritical fluid extraction method using an entrainer addition method may be used.
  • this method for example, ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatics
  • hydrocarbons and ketones are added in an amount of about 2 to 20 w / v%, and this fluid is made into a supercritical fluid state to extract a target substance.
  • the solubility of the target extract such as proanthocyanidins and catechins
  • a bark extract can be obtained.
  • the supercritical fluid extraction method can be operated at relatively low temperatures, so that it can be applied to substances that are degraded and decomposed at high temperatures; the advantage that no extracted fluid remains; and the recycling of solvents is possible, There is an advantage that the desolvation step can be omitted, and the step becomes simple.
  • Extraction from pine bark may be performed by a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, a supercritical carbon dioxide reflux method, or the like, in addition to the above method. Extraction from pine bark can be done by combining multiple extraction methods. By combining a plurality of extraction methods, it is possible to obtain pine peel extracts having various compositions.
  • the pine bark extract obtained by the above extraction is purified by ultrafiltration, column method using an adsorbent carrier (Diaion HP-20, Sephadex-LH20, chitin, etc.) or patch method. Preferred from the aspect of safety, to do.
  • the pine bark extract used in the body fat accumulation inhibitor or body fat reducing agent of the present invention is specifically prepared by the following method, but this is only an example and the present invention is not limited to this method.
  • the step of adding 25 OmL of ethyl acetate to the crude extract, separating the mixture, and collecting the ethyl acetate layer is repeated five times.
  • the collected ethyl acetate solutions are combined, directly added to 200 g of anhydrous sodium sulfate, and dehydrated.
  • the ethyl acetate solution is filtered, and the filtrate is concentrated under reduced pressure to 1/5 of the original volume.
  • the step of dissolving this precipitate in 10 mL of ethyl acetate and adding it again to 1 L of chloroform and precipitating for washing is repeated twice.
  • a pine bark extract containing 20% by mass or more of proanthocyanidins having a degree of polymerization of 2 to 4 and 5% by mass or more of phytotechins is obtained.
  • the content of the specific component in the extract is a value based on the dry mass of the extract. The same applies hereinafter.
  • the pine bark extract used in the present invention contains broantocyanidin as one of the main active ingredients.
  • Proanthocyanidins are a group of compounds consisting of condensed polymers having a degree of polymerization of 2 or more and containing flavan-13-diol and / or flavane-13,4-diol as a structural unit. It is a powerful antioxidant produced by plants and is concentrated in plant leaves, bark, fruit bark, and seeds.
  • This proanthocyanidin is a substance that cannot be produced in the human body When a pine bark extract containing this proanthocyanidin is ingested, an excellent lipid metabolism improving effect can be obtained.
  • the pine bark extract contains a polycondensate having a degree of polymerization of 2 or more as proanthocyanidins, and further contains catechins and the like.
  • proanthocyanidins containing a large amount of polycondensates having a low degree of polymerization are preferably used.
  • the condensation polymer having a low polymerization degree a condensation polymer having a polymerization degree of 2 to 30 (2 to 30 mer) is preferable, and a condensation polymer having a polymerization degree of 2 to 10 (2 to 10 mer).
  • a condensation polymer having a polymerization degree of 2 to 4 is further more preferable.
  • Proanthocyanidins which are polycondensates (2-4 tetramers) with a degree of polymerization of 2-4, are particularly easy to be absorbed into the body, so they not only promote the excretion of cholesterol, but also promote the degradation of medium fats. Can be obtained more effectively.
  • the above polymer having a degree of polymerization of 2 to 4 is referred to as oligomeric proanthocyanidin (hereinafter, referred to as “OPC”).
  • pentamer or more proanthocyanidins have an effect of promoting cholesterol excretion and inhibition of neutral fat absorption.
  • pine bark extract 1.5% by mass, preferably 20% by mass of a polycondensate having a degree of polymerization of 2 to 4 (2 to 4 mer; that is, OPC). / 0 or more, more preferably 30 mass. / 0 in a proportion of, pentamer or more Puroantoshia - Gin 1 0 wt% or more, preferably extracts containing a proportion of more than 1 5% by mass.
  • the pine bark extract contains OPCs and pentamer or more proanthocyanidins, which can enhance cholesterol excretion, suppress fat absorption, and reduce body fat. Conceivable. Such synergistic action improves lipid metabolism in the body.
  • the pine bark extract may further contain catechins, and the catechins are preferably contained in a proportion of 5% by mass or more, more preferably 10% by mass or more.
  • Catechins are produced by the above-mentioned extraction method. It can be extracted with anidine (OPC). Catechins are a general term for polyhydroxyflapan-1-ol.
  • catechins (+) — catechin (referred to as catechin in a narrow sense)
  • Iepicatechin (+) — gallocatechin
  • Iepigallocatechin, epigallocatechin gallate, epika techin gallate, and afzelechin are known.
  • Catechins include carcinogenesis, arteriosclerosis prevention, blood pressure increase suppression, platelet aggregation suppression, antiallergic, antiviral, antibacterial, caries prevention, bad breath prevention, normal intestinal flora It is known to have a chemical effect, a scavenging effect of active oxygen-free radicals, and an anti-acid effect. Also, catechins are known to have an anti-diabetic effect of suppressing an increase in blood sugar. Catechins are poorly water-soluble by themselves and have low physiological activity, but in the presence of OPC, they have the property of increasing water solubility and activating at the same time. Therefore, force technics work effectively when taken with OPC.
  • the catechins are preferably contained in the pine bark extract in an amount of 5% by mass or more. More preferably, the pine bark extract containing 20% by mass or more of OPC and 10% by mass or more of pentamer orchid anthocyanidin preferably contains 5% by mass or more of catechins. For example, when the content of catechins in the pine bark extract is less than 5% by mass, force technics may be added so that the content is 5% by mass or more.
  • a force catechins contained 5 mass 0/0 or more, and most be used 2 0 mass% or more and a degree of polymerization of 5 or more pro-Ant Xia two gin 1 0 pine bark extract you containing mass% or more OPC preferable. (II) Soy peptide
  • the soy peptide used in the present invention is a soy peptide that degrades proteins contained in soy.
  • a soy peptide obtained by Specific examples include whole soybeans, defatted soybean flakes, soymilk, isolated soybean protein, alcohol-extracted soybean protein, soybean whey protein, and the like, which are decomposed by protein hydrolase or acid or alkali treatment.
  • the molecular weight of the soybean peptide varies depending on the conditions of the decomposition treatment, but is not particularly limited in the present invention. Normally, it is sufficient if the weight average molecular weight is hydrolyzed in the range of about 100 to 500,000.
  • Such a soy peptide is more soluble in water than soy protein and has a higher absorption rate from the intestinal tract.
  • a low-molecular-weight soybean peptide obtained by fractionating the above-treated soybean peptide by column chromatography or the like may be used. .
  • Food ingredients that can be added to the food of the present invention include, for example, royal jelly, propolis, vitamins (A, B, C, D, E, K, folic acid, pantothenic acid, biotin, derivatives thereof, etc.), minerals ( Iron, magnesium, calcium, zinc, etc.), selenium, chitin, chitosan, lecithin, polyphenol
  • components such as vitamins and dietary fiber, components that enhance blood sugar level, blood lipids, and lipid metabolism, components that have a blood pressure rise suppressing effect, antithrombotic effects, anti-inflammatory effects,
  • a component having an effect of preventing a disease disease closely related to a cell adhesion factor such as a tumor action can be suitably contained.
  • Such components include, for example, sulfur-containing organic compounds, ubiquinone, heripoic acid, chlorogenic acids, catechins, sapones, mucopolysaccharides, amino sugars, vitamins B, vitamin K, vitamins ⁇ , collagen and the like. Further, hesperidin, quercetin, rutin or derivatives thereof having an antioxidant effect can also be suitably used.
  • additives include excipients, bulking agents, binders, thickeners, and milking agents.
  • Lubricating agents, wetting agents, suspending agents, coloring agents, fragrances, food additives and the like can be added.
  • Body fat accumulation inhibitor or body fat reducing agent contains the above pine peel extract and soybean peptide, and optionally contains other soybean peptides. It may contain functional ingredients, nutritional ingredients, additives and the like. Specifically, using these components, processing usually performed by those skilled in the art is performed to prepare various shapes.
  • the processing method of the body fat accumulation inhibitor or the body fat reducing agent of the present invention is, for example, a method of adding excipients to a pine bark extract and a soy peptide to form a tablet, a pill or the like.
  • examples thereof include a method of forming a powder and other forms without molding.
  • Other dosage forms include capsules such as hard capsules and soft capsules, powders, granules, liquids, and pastes. It can also be processed into tea bags, candy, etc.
  • the method of ingesting the body fat accumulation inhibitor or body fat reducing agent of the present invention is not particularly limited.
  • the body fat accumulation inhibitor or body fat reducing agent may be eaten or consumed as it is, or may be dissolved in water, hot water, milk, etc., depending on its shape or preference, or may be leached from its ingredients You may drink.
  • the body fat accumulation inhibitor or body fat reducing agent of the present invention generally contains pine bark extract in a body fat accumulation inhibitor or a body fat reducing agent in an amount of 0.0001 to 50% by mass. % Is preferably contained.
  • the amount of the body fat accumulation inhibitor or body fat reducing agent of the present invention is set to 0.001 g per day as the lower limit of the pine bark extract.
  • the weight is preferably 0.02 g or more, more preferably 0.02 g or more, and most preferably 0.04 g or more.
  • the daily intake is 2.0 g or less, preferably 1.0 g or less, more preferably 0.6 g or less as the upper limit of proanthocyanidins.
  • soybean used for the body fat accumulation inhibitor or body fat reducing agent of the present invention is preferably 1 part by mass to 2000 parts by mass, and more preferably 10 parts by mass to 100 parts by mass with respect to 100 parts by mass of the dry weight of the pine bark extract.
  • the parts by mass are more preferable, and the parts by mass of 100 to 100 parts by mass are more preferable.
  • the food of the present invention contains a pine bark extract and a soy peptide.
  • the pine bark extract has a unique flavor, for example, bitterness and astringency derived from components contained in the pine bark extract, as well as bark-specific astringency.
  • soy beptide By blending soy beptide, the flavor unique to pine bark is masked and has excellent palatability. This makes it easier to incorporate the pine bark extract into foods and makes it possible to apply it to various dosage forms.
  • the amount of the soybean peptide in the pine bark extract for obtaining such a masking effect is not particularly limited, but is preferably 100 parts by mass (dry mass) of the pine bark extract. It is preferable to add the peptide in an amount of 100 parts by mass (dry mass) or more.
  • mice Fourteen 7-week-old female ICR mice (CLEA Japan, Inc.) were acclimated to a basic diet (MF diet, Oriental Yeast Co., Ltd.) for 1 week. Then, each group was divided into two groups so that the average body weight was almost the same. Next, 40 mass% of tallow and 9 mass of granulated sugar were added to a group of mice. /. , And a test feed containing 5% by mass of the above pine bark extract was allowed to freely ingest (test group). The remaining one group of mice was fed a control diet similar to the test diet but without pine bark extract alone (the control group).
  • Rate of increase (%) (weight of body weight before ingestion 25-body weight before ingestion) weight before ingestion X 1 00 ⁇ 1 (I)
  • the subcutaneous fat was measured by X-ray CT for laboratory animals (trade name: LAT heata; Aro Rikisha). Then, retroperitoneal fat and peripheral fat were excised, and the total mass of these fats (mass of visceral fat) was measured. Further, the blood collected from the fundus of each mouse was used to measure the triglyceride level in the blood using a triglyceride measurement kit (Wako Pure Chemical Industries, Ltd.). Table 1 shows the results.
  • test group 1 Fifteen 7-week-old female ICR mice (CLEA Japan) were acclimated to a basic diet (MF diet, Oriental Yeast Co., Ltd.) for 1 week. Then, each group was divided into three groups so that the average body weight was almost the same. Next, one group of mice contains 4% by mass of beef tallow, 9% by mass of granulated sugar, 2% by mass of the above pine bark extract, and 5% by mass of soybean peptide (Fuji Oil Co., Ltd.) The test feed 1 was freely taken (referred to as test group 1). The other group was allowed to freely ingest comparative diet 1 prepared in the same manner as trial diet 1 except that it did not contain the pine bark extract of trial diet 1 (comparative group 1). The remaining groups were allowed free access to comparative feed 2 prepared in the same manner as test feed 1 except that they did not contain the pine bark extract and soy beptide of test feed 1 (comparison group 2). ).
  • the values are the mean soil standard deviation
  • the test feed containing pine bark extract and soybean peptide 1 was the comparative feed containing only soybean peptide and the comparative feed containing no pine bark extract and soybean peptide. It was found to have an excellent effect of suppressing or reducing the accumulation of body fat as compared to 2.
  • the body fat accumulation inhibitor or the body fat reducing agent of the present invention can be used in combination with soy beptide, even when the pine bark extract content is small, to contain only the pine bark extract of Reference Example 1. It was found that the same effect as the feed could be exerted.
  • the food containing the pine bark extract and soy beptide of the present invention is a food in which the flavor peculiar to pine bark is reduced and has excellent palatability.
  • soybean peptide in the same amount or more as the pine bark extract, it becomes possible to have more excellent palatability.
  • Industrial applicability ADVANTAGE OF THE INVENTION According to this invention, the accumulation
  • OPC in the pine bark extract is easily absorbed into the body, promotes the excretion of cholesterol and the breakdown of neutral fats in the body, and is thought to have the effect of efficiently metabolizing fats. Excellent effects can be obtained by combining the action of the pine bark extract with the soybean peptide.
  • the combination of the pine bark extract and the soy peptide reduces the peculiar flavor of the pine bark extract and makes the food excellent in palatability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A body fat reducing preparation or body fat deposition inhibitor comprising an extract from the bark of pine and a soybean peptide. This body fat deposition inhibitor or body fat reducing preparation exhibits an excellent body fat deposition inhibiting effect or reducing effect.

Description

明 細 書 松樹皮抽出物を含有する食品 技術分野  Description Food technology containing pine bark extract
松樹皮抽出物と大豆べプチドとを含有する体脂肪蓄積抑制剤または体脂肪 低減剤に関する。 より詳細には、 松樹皮抽出物と大豆ペプチドとを含有する 食品に関する。 背景技術  The present invention relates to a body fat accumulation inhibitor or a body fat reducing agent containing a pine bark extract and soy beptide. More specifically, the present invention relates to a food containing a pine bark extract and a soybean peptide. Background art
最近は飽食の時代と言われ、 消費カロリー量に対して摂取カロリー量が多 くなる傾向にあり、 過剰に摂取されたカロリーは、 体脂肪、 皮下脂肪、 ある いは肝臓中に脂肪として蓄積される。 特に、 中高年の人にとって脂肪の蓄積 は、 肥満の原因になり、 またそれによつて引き起こされる成人病、 例えば、 高血圧、 脂肪肝、 肝炎、 肝硬変などがあるが、 これらのことは、 社会問題に もなつている。 このような背景から、 3 -ラクトグロブリンを有効成分とす る脂質代謝改善剤 (特開平 8— 2 5 9 4 6 1号公報) 、 グアバ葉、 ホップ、 ラフマ葉、 ギムネマ葉、 およびサンシンから選ばれる 1種または 2種以上の 生薬またはそれらの抽出物を含有するリパーゼ阻害剤 (特開 2 0 0 1— 2 2 6 2 7 4号公報) などが開示されている。 発明の開示  Recently, it is said that people are in a period of satiety, and the calorie intake tends to be higher than the calorie consumption.Excessive calories are accumulated as body fat, subcutaneous fat, or fat in the liver. You. In particular, fat accumulation in middle-aged and elderly people causes obesity and the resulting adult diseases, such as high blood pressure, fatty liver, hepatitis, and cirrhosis. I'm familiar. Against this background, it is selected from lipid metabolism improvers containing 3-lactoglobulin as an active ingredient (Japanese Patent Application Laid-Open No. Hei 8-259461), guava leaves, hops, rafuma leaves, gymnema leaves, and sanshin. And lipase inhibitors containing one or more crude drugs or extracts thereof (Japanese Patent Application Laid-Open No. 2001-226274). Disclosure of the invention
しかし、 肥満を解消するために、 上記のような成分を含有する脂質代謝改 善剤などが提案されていても、 それぞれの成分が有する効果は、 肥満の原因 の一側面に対する効果に過ぎず、 その効果は体質および食生活によって大き く変化するのが現状である。 このため、 複数の肥満を解消する成分を組み合 わせることによって、 様々な体質や食生活に対応しえるようにすることも考 えられる。 しかし、 組み合わせる成分によって、 効果が異なるという問題点 がある。 However, even if lipid metabolism-improving agents containing the above-mentioned components have been proposed to eliminate obesity, the effect of each component is only an effect on one aspect of the cause of obesity. At present, the effects vary greatly depending on constitution and dietary habits. For this reason, a combination of multiple ingredients that eliminate obesity By doing so, it may be possible to respond to various constitutions and dietary habits. However, there is a problem that the effect differs depending on the components to be combined.
本発明者らは、 上記課題に鑑み、 体脂肪の蓄積抑制効果または低減効果を 有する成分の組合せについて鋭意検討を行った。 その結果、 大豆ペプチドと 松樹皮抽出物とを含有する食品を調製することによって、 優れた体脂肪の蓄 積抑制効果または低減効果が得られることを見出し、 本発明に至った。  In view of the above problems, the present inventors have intensively studied a combination of components having an effect of suppressing or reducing the accumulation of body fat. As a result, they have found that by preparing a food containing a soybean peptide and a pine bark extract, an excellent effect of suppressing or reducing the accumulation of body fat can be obtained, leading to the present invention.
すなわち、 本発明は、 松榭皮抽出物と大豆ペプチドとを含有する体脂肪蓄 積抑制剤または体脂肪低減剤に関する。  That is, the present invention relates to a body fat accumulation inhibitor or a body fat reducing agent containing a pine peel extract and a soybean peptide.
また、 本発明は、 松樹皮抽出物と大豆ペプチドとを含有する食品に関する。 本発明によれば、 松樹皮抽出物と大豆べプチドとを含有する体脂肪蓄積抑 制剤または体脂肪低減剤は、 これらを組み合わせることにより優れた体脂肪 の蓄積抑制効果または低減効果を発揮する。 特に、 松樹皮抽出物中の O P C は体内に吸収されやすく、 体内において、 コレステロールの排泄および中性 脂肪の分解を促進し、 効率よく脂肪を代謝させる作用があると考えられる。 また、 松樹皮抽出物と大豆ペプチドとを含有する食品は、 松樹皮抽出物の 特有の風味を大豆ぺプチドが低減し、 嗜好性に優れた食品となる。 発明を実施するための最良の形態  The present invention also relates to a food containing a pine bark extract and a soy peptide. According to the present invention, a body fat accumulation inhibitor or a body fat reducer containing a pine bark extract and soy beptide exhibits an excellent body fat accumulation inhibitory or reducing effect by combining them. . In particular, OPC in the pine bark extract is likely to be absorbed into the body, and promotes the excretion of cholesterol and the decomposition of neutral fats in the body, which is considered to have the effect of efficiently metabolizing fats. In addition, a food containing a pine bark extract and a soy peptide is a food excellent in palatability because the soy peptide reduces the characteristic flavor of the pine bark extract. BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明の実施形態について説明する。 なお、 本発明は、 下記実施形 態の記載により限定して解釈するべきでなく、 特許請求の範囲における記載 の範囲内で種々の変更が可能である。  Hereinafter, embodiments of the present invention will be described. The present invention should not be construed as being limited by the description of the following embodiments, and various changes can be made within the scope of the claims.
( I ) 松樹皮抽出物 (I) Pine bark extract
松樹皮抽出物の原料となる松樹皮としては、 フランス海岸松 (Pinus Mart ima) 、 カラマツ、 クロマツ、 ァカマツ、 ヒメコマツ、 ゴヨウマツ、 チョウ センマツ、 ハイマツ、 リュウキユウマツ、 ゥックシマツ、 ダイォゥマツ、 シ 口マツ、 およびカナダのケベック地方のァネダなどのマツ目に属する植物の 樹皮が好ましく用いられる。 中でも、 フランス海岸松 (Pinus Martima) の 樹皮が好ましく用いられる。 The pine bark used as the raw material for the pine bark extract is French pine (Pinus Mart ima), larch, Japanese black pine, Japanese pine, Japanese pine, Japanese pine, and butterfly. The bark of a plant belonging to the order Pinaceae, such as Satsumamatsu, Himatsu, Ryukyuenmatsu, Pakshimatsu, Daiomatsu, Shiguchimatsu, and Aneda in Quebec, Canada is preferably used. Above all, bark of French pine (Pinus Martima) is preferably used.
フランス海岸松は、 南仏の大西洋沿岸の一部に生育している海洋性松をい う。 このフランス'海岸松の榭皮は、 プロアントシァニジン、 有機酸、 その他 の生理活性成分などを含有する。  French pine is a marine pine that grows on part of the Atlantic coast of southern France. The skin of this French shore pine contains proanthocyanidins, organic acids, and other bioactive ingredients.
本発明に用いられる松樹皮抽出物は、 上記の松の樹皮を水または有機溶媒 で抽出して得られる。 水を用いる場合には、 温水または熱水が用いられる。 有機溶媒を用いる場合には、 食品あるいは薬剤の製造に許容される溶媒が用 いられ得る。 このような有機溶媒としては、 例えば、 メタノール、 エタノー ノレ、 1—プロノ ノーノレ、 2—プロノ ノーノレ、 1—プタノーノレ、 2—ブタノー ル、 アセトン、 へキサン、 、ンク口へキサン、 プロピレングリコール、 含水ェ タノール、 含水プロピレングリコール、 メチルェチルケトン、 グリセリン、 酢酸メチル、 酢酸ェチル、 ジェチルエーテル、 ジクロロメタン、 食用油脂、 1 , 1 , 1 , 2—テトラフルォロェタン、 および 1 , 1, 2 _トリクロロェ テンが挙げられる。 これらの水およぴ有機溶媒は単独で用いられてもよいし 2種類以上が併用されてもよい。 特に、 水、 エタノール、 含水エタノール、 および含水プロピレンダリコールが好ましく用いられる。 食品または医薬品 に用いる場合の安全性の観点から、 水、 エタノール、 および含水エタノール がより好ましく、 加温して抽出することがより好ましい。  The pine bark extract used in the present invention is obtained by extracting the pine bark with water or an organic solvent. If water is used, hot or hot water is used. When an organic solvent is used, a solvent acceptable for the production of foods or drugs can be used. Examples of such an organic solvent include methanol, ethanol, 1-prono-nore, 2-prono-nore, 1-ptano-nore, 2-butanol, acetone, hexane, hexane, hexane, propylene glycol, and hydrous alcohol. Tanol, hydrous propylene glycol, methylethyl ketone, glycerin, methyl acetate, ethyl acetate, getyl ether, dichloromethane, edible fats and oils, 1,1,1,2-tetrafluoroethane, and 1,1,2-trichloroethane Tens. These water and organic solvent may be used alone or in combination of two or more. In particular, water, ethanol, aqueous ethanol, and aqueous propylene dalicol are preferably used. From the viewpoint of safety when used for foods or pharmaceuticals, water, ethanol, and hydrous ethanol are more preferable, and it is more preferable to extract by heating.
松樹皮からの抽出方法に特に制限はないが、 例えば、 加温抽出法、 超臨界 流体抽出法などが用いられる。  There is no particular limitation on the extraction method from the pine bark, and for example, a heating extraction method, a supercritical fluid extraction method, or the like is used.
超臨界流体抽出法は、 物質の気液の臨界点 (臨界温度、 臨界圧力) を超え た状態の流体である超臨界流体を用いて抽出を行う方法である。 超臨界流体 としては、 二酸化炭素、 エチレン、 プロパン、 亜酸化窒素 (笑気ガス) など が用いられ、 二酸ィ匕炭素が好ましく用いられる。 Supercritical fluid extraction is a method in which a substance is extracted using a supercritical fluid, which is a fluid that has exceeded the critical point (critical temperature, critical pressure) of gas-liquid. Supercritical fluids include carbon dioxide, ethylene, propane, nitrous oxide (laughing gas), etc. And diacid carbon is preferably used.
超臨界流体抽出法は、 目的成分を超臨界流体によって抽出する抽出ェ 、 およぴ目的成分と超臨界流体とを分離する分離工程とからなる。 分離工程で は、 圧力変化による抽出分離、 温度変化による抽出分離、 または吸着剤 ·吸 収剤を用いた抽出分離のいずれを行ってもよい。  The supercritical fluid extraction method includes an extraction step of extracting a target component with a supercritical fluid, and a separation step of separating the target component from the supercritical fluid. In the separation step, any of extraction separation by pressure change, extraction separation by temperature change, and extraction separation using an adsorbent / absorbent may be performed.
また、 ェントレーナー添加法による超臨界流体抽出法を用いてもよい。 こ の方法は、 超臨界流体を形成し得る上記流体に、 例えば、 エタノール、 プロ パノール、 n—へキサン、 アセトン、 トルエン、 その他の脂肪族低級アルコ ール類、 脂肪族炭化水素類、 芳香族炭化水素類、 およぴケトン類を 2〜 2 0 w/v%程度添加し、 この流体を超臨界流体状態として目的物質を抽出する 方法である。 この方法によれば、 プロアントシァニジンおよびカテキン類な どの目的とする抽出物の抽出溶媒に対する溶解度を飛躍的に上昇でき、 また は分離の選択性を増強させることができるので、 効率的に松樹皮抽出物を得 ることができる。  Further, a supercritical fluid extraction method using an entrainer addition method may be used. In this method, for example, ethanol, propanol, n-hexane, acetone, toluene, other aliphatic lower alcohols, aliphatic hydrocarbons, aromatics In this method, hydrocarbons and ketones are added in an amount of about 2 to 20 w / v%, and this fluid is made into a supercritical fluid state to extract a target substance. According to this method, the solubility of the target extract, such as proanthocyanidins and catechins, in the extraction solvent can be dramatically increased, or the selectivity of separation can be enhanced. A bark extract can be obtained.
超臨界流体抽出法は、 比較的低い温度で操作できるため、 高温で変質 '分 角军する物質にも適用できるという利点;抽出流体が残留しないという利点; および溶媒の循環利用が可能であり、 脱溶媒工程などが省略でき、 工程がシ ンプルになるという利点がある。  The supercritical fluid extraction method can be operated at relatively low temperatures, so that it can be applied to substances that are degraded and decomposed at high temperatures; the advantage that no extracted fluid remains; and the recycling of solvents is possible, There is an advantage that the desolvation step can be omitted, and the step becomes simple.
また、 松樹皮からの抽出は、 上記の方法以外に、 液体二酸化炭素回分法、 液体二酸化炭素還流法、 超臨界二酸化炭素還流法などにより行ってもよい。 松樹皮からの抽出は、 複数の抽出方法を組み合わせてもよレ、。 複数の抽出 方法を組み合わせることにより、 種々の組成の松榭皮抽出物を得ることが可 能となる。  Extraction from pine bark may be performed by a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, a supercritical carbon dioxide reflux method, or the like, in addition to the above method. Extraction from pine bark can be done by combining multiple extraction methods. By combining a plurality of extraction methods, it is possible to obtain pine peel extracts having various compositions.
上記抽出により得られた松樹皮抽出物は、 限外濾過、 吸着性担体 (ダイヤ イオン H P— 2 0、 S e p h a d e x— L H 2 0、 キチンなど) を用いた力 ラム法、 またはパッチ法により精製を行うことが安全性の面から好ましレ、。 本発明の体脂肪蓄積抑制剤または体脂肪低減剤に用いられる松樹皮抽出物 は、 具体的には、 以下のような方法により調製されるが、 これは例示であり、 この方法に限定されない。 The pine bark extract obtained by the above extraction is purified by ultrafiltration, column method using an adsorbent carrier (Diaion HP-20, Sephadex-LH20, chitin, etc.) or patch method. Preferred from the aspect of safety, to do. The pine bark extract used in the body fat accumulation inhibitor or body fat reducing agent of the present invention is specifically prepared by the following method, but this is only an example and the present invention is not limited to this method.
フランス海岸松の樹皮 1 k gを、 塩化ナトリゥムの飽和水溶液 3 Lに入れ、 1 0 0 °Cにて 3 0分間抽出し、 抽出液を得る (抽出工程) 。 その後、 抽出液 を濾過し、 得られる不溶物を塩ィヒナトリゥムの飽和溶液 5 0 O m Lで洗浄し、 洗浄液を得る (洗浄工程) 。 この抽出液と洗浄液を合わせて、 松樹皮の粗抽 出液を得る。  1 kg of French pine bark is placed in 3 L of a saturated aqueous solution of sodium chloride and extracted at 100 ° C for 30 minutes to obtain an extract (extraction step). Thereafter, the extract is filtered, and the resulting insolubles are washed with 50 OmL of a saturated solution of chickpea sodium to obtain a washing solution (washing step). The extract and the washing solution are combined to obtain a crude extract of pine bark.
次いで、 この粗抽出液に酢酸ェチル 2 5 O m Lを添カ卩して分液し、 酢酸ェ チル層を回収する工程を 5回繰り返す。 回収した酢酸ェチル溶液を合わせて、 無水硫酸ナトリウム 2 0 0 gに直接添加して脱水する。 その後、 この酢酸ェ チル溶液を濾過し、 濾液を元の 5分の 1量になるまで減圧濃縮する。 濃縮さ れた酢酸ェチル溶液を 2 Lのクロロホルムに注ぎ、 攪拌して得られる沈殿物 を濾過して回収する。 その後、 この沈殿物を酢酸ェチル 1 0 O m Lに溶解し た後、 再度 1 Lのクロ口ホルムに添加して洗浄するため沈殿させる工程を 2 回繰り返す。 この方法により、 例えば、 重合度が 2〜4のプロアントシァニ ジンを 2 0質量%以上含有し、 かつ力テキン類を 5質量%以上含有する、 約 5 gの松樹皮抽出物が得られる。 ここで、 抽出物中の特定の成分の含有量は、 抽出物の乾燥質量を基準とした値である。 以下、 同様である。  Next, the step of adding 25 OmL of ethyl acetate to the crude extract, separating the mixture, and collecting the ethyl acetate layer is repeated five times. The collected ethyl acetate solutions are combined, directly added to 200 g of anhydrous sodium sulfate, and dehydrated. Then, the ethyl acetate solution is filtered, and the filtrate is concentrated under reduced pressure to 1/5 of the original volume. Pour the concentrated ethyl acetate solution into 2 L of chloroform and stir to collect the resulting precipitate by filtration. After that, the step of dissolving this precipitate in 10 mL of ethyl acetate and adding it again to 1 L of chloroform and precipitating for washing is repeated twice. By this method, for example, about 5 g of a pine bark extract containing 20% by mass or more of proanthocyanidins having a degree of polymerization of 2 to 4 and 5% by mass or more of phytotechins is obtained. Here, the content of the specific component in the extract is a value based on the dry mass of the extract. The same applies hereinafter.
本発明に用いられる松樹皮抽出物は、 主な有効成分の一つとして、 ブロア ントシァニジンを含有する。 プロアントシァニジンは、 フラバン一 3—ォー ルおよび/またはフラパン一 3, 4ージオールを構成単位とする重合度が 2 以上の縮重合体からなる化合物群をいう。 植物が作り出す強力な抗酸化物質 であり、 植物の葉、 樹皮、 果実の皮、 および種に集中的に含まれている。 こ のプロアントシァニジンは、 ヒ トの体内では生成することができない物質で める このプロアントシァニジンを含有する松樹皮抽出物を摂取した場合に、 優 れた脂質代謝改善効果が得られる。 松樹皮抽出物には、 プロアントシァニジ ンとして重合度が 2以上の縮重合体が含有され、 さらにカテキンなどが含有 される。 特に、 重合度が低い縮重合体が多く含まれるプロアントシァニジン が好ましく用いられる。 重合度の低い縮重合体としては、 重合度が 2〜3 0 の縮重合体 (2〜3 0量体) が好ましく、 重合度が 2〜1 0の縮重合体 (2 〜1 0量体) がより好ましく、 重合度が 2〜4の縮重合体 (2〜4量体) が さらに好ましい。 重合度が 2 ~ 4の縮重合体 (2〜4量体) のプロアントシ ァニジンは、 特に体内に吸収されやすいため、 コレステロールの排泄促進作 用の他に、 中†生脂肪の分解促進などの作用がより効果的に得られると考えら れる。 本明細書では、 上記の重合度が 2〜4の重合体を、 オリゴメリック ' プロアントシァニジン (oligomeric proanthocyanidin、 以下 「O P C」 と レヽう) とレヽう。 The pine bark extract used in the present invention contains broantocyanidin as one of the main active ingredients. Proanthocyanidins are a group of compounds consisting of condensed polymers having a degree of polymerization of 2 or more and containing flavan-13-diol and / or flavane-13,4-diol as a structural unit. It is a powerful antioxidant produced by plants and is concentrated in plant leaves, bark, fruit bark, and seeds. This proanthocyanidin is a substance that cannot be produced in the human body When a pine bark extract containing this proanthocyanidin is ingested, an excellent lipid metabolism improving effect can be obtained. The pine bark extract contains a polycondensate having a degree of polymerization of 2 or more as proanthocyanidins, and further contains catechins and the like. In particular, proanthocyanidins containing a large amount of polycondensates having a low degree of polymerization are preferably used. As the condensation polymer having a low polymerization degree, a condensation polymer having a polymerization degree of 2 to 30 (2 to 30 mer) is preferable, and a condensation polymer having a polymerization degree of 2 to 10 (2 to 10 mer). ) Is more preferable, and a condensation polymer having a polymerization degree of 2 to 4 (a dimer to a tetramer) is further more preferable. Proanthocyanidins, which are polycondensates (2-4 tetramers) with a degree of polymerization of 2-4, are particularly easy to be absorbed into the body, so they not only promote the excretion of cholesterol, but also promote the degradation of medium fats. Can be obtained more effectively. In the present specification, the above polymer having a degree of polymerization of 2 to 4 is referred to as oligomeric proanthocyanidin (hereinafter, referred to as “OPC”).
また、 5量体以上のプロアントシァニジンは、 コレステロールの排泄およ ぴ中性脂肪の吸収阻害を促進する作用を有すると考えられる。 松樹皮抽出物 としては、 重合度が 2〜4の縮重合体 (2〜4量体;すなわち、 O P C ) を 1. 5質量%、 好ましくは 2 0質量。 /0以上、 より好ましくは 3 0質量。 /0の割合 で含有し、 5量体以上のプロアントシァ-ジンを 1 0質量%以上、 好ましく は 1 5質量%以上の割合で含有する抽出物が好ましい。 上記のように松樹皮 抽出物においては、 O P Cおよび 5量体以上のプロアントシァニジンが含ま れていることにより、 コレステロールの排泄促進作用、 脂肪吸収抑制作用、 体脂肪低減作用などが得られると考えられる。 このような相乗的な作用によ り、 体内における脂質代謝が改善される。 It is considered that pentamer or more proanthocyanidins have an effect of promoting cholesterol excretion and inhibition of neutral fat absorption. As the pine bark extract, 1.5% by mass, preferably 20% by mass of a polycondensate having a degree of polymerization of 2 to 4 (2 to 4 mer; that is, OPC). / 0 or more, more preferably 30 mass. / 0 in a proportion of, pentamer or more Puroantoshia - Gin 1 0 wt% or more, preferably extracts containing a proportion of more than 1 5% by mass. As described above, the pine bark extract contains OPCs and pentamer or more proanthocyanidins, which can enhance cholesterol excretion, suppress fat absorption, and reduce body fat. Conceivable. Such synergistic action improves lipid metabolism in the body.
上記松樹皮抽出物には、 さらにカテキン (catechin) 類が含有され得、 こ のカテキン類は、 好ましくは 5質量%以上、 より好ましくは 1 0質量%以上 の割合で含有される。 カテキン類は、 上記抽出方法によ όて、 プロアントシ ァニジン (O P C ) とともに抽出され得る。 カテキン類とは、 ポリヒドロキ シフラパン一 3—オールの総称である。 カテキン類としては、 (+ ) —カテ キン (狭義のカテキンといわれる) 、 (一) 一ェピカテキン、 (+) —ガロ カテキン、 (一) 一ェピガロカテキン、 ェピガロカテキンガレート、 ェピカ テキンガレート、 ァフゼレキンなどが知られている。 上記松樹皮抽出物から は、 上記の (+ ) 一力テキンの他、 ガロカテキン、 ァフゼレキン、 ならびに (+ ) —力テキンまたはガロカテキンの 3—ガロイル誘導体が単離されてい る。 カテキン類には、 発癌抑制作用、 動脈硬化予防作用、 血圧上昇の抑制作 用、 血小板凝集抑制作用、 抗アレルギー作用、 抗ウィルス作用、 抗菌作用、 虫歯予防作用、 口臭防止作用、 腸内細菌叢正常化効果、 活性酸素ゃフリーラ ジカルの消去作用、 抗酸ィヒ作用などがあることが知られている。 また、 カテ キン類には、 血糖の上昇を抑制する抗糖尿病効果があることが知られている。 カテキン類は、 単独では水溶性が乏しく、 その生理活性が低いが、 O P Cの 存在下では、 水溶性が増すと同時に活性化する性質がある。 従って、 力テキ ン類は O P Cとともに摂取することで効果的に作用する。 The pine bark extract may further contain catechins, and the catechins are preferably contained in a proportion of 5% by mass or more, more preferably 10% by mass or more. Catechins are produced by the above-mentioned extraction method. It can be extracted with anidine (OPC). Catechins are a general term for polyhydroxyflapan-1-ol. As catechins, (+) — catechin (referred to as catechin in a narrow sense), (1) Iepicatechin, (+) — gallocatechin, (1) Iepigallocatechin, epigallocatechin gallate, epika techin gallate, and afzelechin Are known. From the pine bark extract, gallocatechin, afzelechin, and a 3-galloyl derivative of (+)-force tekin or gallocatechin have been isolated in addition to the (+) force tekin described above. Catechins include carcinogenesis, arteriosclerosis prevention, blood pressure increase suppression, platelet aggregation suppression, antiallergic, antiviral, antibacterial, caries prevention, bad breath prevention, normal intestinal flora It is known to have a chemical effect, a scavenging effect of active oxygen-free radicals, and an anti-acid effect. Also, catechins are known to have an anti-diabetic effect of suppressing an increase in blood sugar. Catechins are poorly water-soluble by themselves and have low physiological activity, but in the presence of OPC, they have the property of increasing water solubility and activating at the same time. Therefore, force technics work effectively when taken with OPC.
カテキン類は、 上記松樹皮抽出物に、 5質量%以上含有されていることが 好ましい。 より好ましくは、 O P Cを 2 0質量%以上、 かつ 5量体以上のプ 口アントシァニジンを 1 0質量%以上含有する松樹皮抽出物に、 カテキン類 が 5質量%以上含有されるのが好ましい。 例えば、 松樹皮抽出物のカテキン 類含有量が 5質量%未満の場合、 含有量が 5質量%以上となるように力テキ ン類を添加してもよい。 力テキン類を 5質量0 /0以上含有し、 O P Cを 2 0質 量%以上、 かつ 5量体以上のプロアントシァニジンを 1 0質量%以上含有す る松樹皮抽出物を用いることが最も好ましい。 ( I I ) 大豆ペプチド The catechins are preferably contained in the pine bark extract in an amount of 5% by mass or more. More preferably, the pine bark extract containing 20% by mass or more of OPC and 10% by mass or more of pentamer orchid anthocyanidin preferably contains 5% by mass or more of catechins. For example, when the content of catechins in the pine bark extract is less than 5% by mass, force technics may be added so that the content is 5% by mass or more. A force catechins contained 5 mass 0/0 or more, and most be used 2 0 mass% or more and a degree of polymerization of 5 or more pro-Ant Xia two gin 1 0 pine bark extract you containing mass% or more OPC preferable. (II) Soy peptide
本発明に用いる大豆ペプチドとは、 大豆中に含まれるタンパク質を分解し て得られるペプチドをいう。 具体的には、 丸大豆、 脱脂大豆フレーク、 豆乳、 分離大豆タンパク、 アルコール抽出大豆タンパク、 大豆ホエータンパクなど を、 蛋白質加水分解酵素または酸もしくはアルカリ処理により分解したもの が挙げられる。 また、 大豆ペプチドは、 分解処理の条件によって分子量が異 なるが、 本発明においては特に制限するものではない。 通常、 重量平均分子 量が約 1 0 0〜5 0 0 0 0の範囲に加水分解されているものであればよい。 このような大豆ペプチドは、 大豆タンパク質よりも水への溶解性がよく、 腸 管からの吸収率も高い。 栄養をより効率的に吸収させるまたは水への溶解性 を向上させる目的から、 上記処理した大豆ペプチドをカラムクロマトグラフ ィーなどによって分取して得られる低分子量の大豆べプチドを用いても良い。 The soy peptide used in the present invention is a soy peptide that degrades proteins contained in soy. Refers to a peptide obtained by Specific examples include whole soybeans, defatted soybean flakes, soymilk, isolated soybean protein, alcohol-extracted soybean protein, soybean whey protein, and the like, which are decomposed by protein hydrolase or acid or alkali treatment. Further, the molecular weight of the soybean peptide varies depending on the conditions of the decomposition treatment, but is not particularly limited in the present invention. Normally, it is sufficient if the weight average molecular weight is hydrolyzed in the range of about 100 to 500,000. Such a soy peptide is more soluble in water than soy protein and has a higher absorption rate from the intestinal tract. For the purpose of more efficiently absorbing nutrients or improving solubility in water, a low-molecular-weight soybean peptide obtained by fractionating the above-treated soybean peptide by column chromatography or the like may be used. .
( I I I ) その他の機能性成分 (I I I) Other functional ingredients
本発明の食品に添加可能な食品原料としては、 例えば、 ローヤルゼリー、 プロポリス、 ビタミン類 (A、 B群、 C、 D、 E、 K、 葉酸、 パントテン酸、 ピオチン、 これらの誘導体など) 、 ミネラル (鉄、 マグネシウム、 カルシゥ ム、 亜 など) 、 セレン、 キチン 'キトサン、 レシチン、 ポリフエノーノレ Food ingredients that can be added to the food of the present invention include, for example, royal jelly, propolis, vitamins (A, B, C, D, E, K, folic acid, pantothenic acid, biotin, derivatives thereof, etc.), minerals ( Iron, magnesium, calcium, zinc, etc.), selenium, chitin, chitosan, lecithin, polyphenol
(カテキン類、 アントシァニン類、 プロアントシァニジンなどの縮合型タン ニン、 ガロタンユンなどの加水分解型タンニン、 イソフラボン類、 フラボノ イド類、 クロロゲン酸類、 これらの誘導体など) 、 カロテノイド (リコピン、 ァスタキサンチン、 ゼアキサンチン、 ルティンなど) 、 サポニン (ジンセサ ノイド、 グリチルリチン酸、 ギムネマ酸など) 、 キサンチン誘導体 (カフェ インなど) 、 脂肪酸、 アミノ酸、 タンパク質 (コラーゲン、 エラスチンな ど) 、 大豆ペプチド以外のペプチド (コラーゲンペプチド、 エラスチンぺプ チド、 イワシペプチドなど) 、 ムコ多糖類 (ヒアルロン酸、 コンドロイチン、 デ マタン、 へパラン、 へパリン、 ケタラン、 これらの塩など) 、 ァミノ糖 (グルコサミン、 ァセチルダルコサミン、 ガラクトサミン、 ァセチルガラク トサミン、 ノィラミン酸、 ァセチルノイラミン酸、 へキソサミン、 それらの 塩など) 、 食物繊維 (難消化性デキストリン、 アルギン酸、 グァガム、 ぺク チン、 ダルコマンナンなど) 、 オリゴ糖 (イソマルトオリゴ糖、 環状オリゴ 糖など) リン脂質およびスフインゴ脂質またはそれらの誘導体 (フォスファ チジルコリン、 スフインゴミエリン、 セラミドなど) 、 含硫化合物 (ァリイ ン、 セパェン、 タウリン、 グルタチオン、 メチルスルホニルメタンなど) 、 糖アルコール、 キノン類 (コェンザィム Q 1 0など) 、 リグナン類 (セサミ ンなど) 、 これらを含有する動植物抽出物、 根菜類 (ゥコン、 ショウガな ど) 、 麦若葉末などのイネ科植物の緑葉、 ケールなどのアブラナ科植物の緑 葉などが挙げられる。 (Catechins, anthocyanins, condensed tannins such as proanthocyanidins, hydrolysed tannins such as gallotannine, isoflavones, flavonoids, chlorogenic acids, derivatives thereof), carotenoids (lycopene, astaxanthin, Zeaxanthin, rutin, etc., saponin (ginsesanoid, glycyrrhizic acid, gymnemic acid, etc.), xanthine derivatives (caffeine, etc.), fatty acids, amino acids, proteins (collagen, elastin, etc.), peptides other than soybean peptides (collagen peptides, elastin, etc.) Peptides, sardine peptides, etc.), mucopolysaccharides (hyaluronic acid, chondroitin, dematane, heparan, heparin, ketalan, salts thereof, etc.), and amino sugars (glucosamine, aceti Darukosamin, galactosamine, Asechirugaraku Tosamine, neuraminic acid, acetyl neuraminic acid, hexosamine, their salts, etc., dietary fiber (digestible dextrin, alginic acid, guar gum, pectin, dalcomannan, etc.), oligosaccharides (isomaltooligosaccharides, cyclic oligos) Sugar, etc.) Phospholipids and sphingolipids or their derivatives (phosphatidylcholine, sphingomyelin, ceramide, etc.), sulfur-containing compounds (aliyne, sephaen, taurine, glutathione, methylsulfonylmethane, etc.), sugar alcohols, quinones (koenzym) Q10), lignans (sesamin, etc.), animal and plant extracts containing them, root crops (ゥ kon, ginger, etc.), green leaves of grasses such as young wheat leaf, and cruciferous plants such as kale. Green leaves and the like.
上記機能性成分のうち、 ビタミン類、 食物繊維などの成分、 血糖値、 血中 脂質、 および脂質の代謝を亢進する成分、 血圧の上昇抑制作用を有する成分、 抗血栓作用、 抗炎症作用、 抗腫瘍作用など、 細胞接着因子との関わりの深い 疾病疾患を予防する効果を有する成分が好適に含有され得る。 このような成 分としては、 例えば、 含硫有機化合物、 ュビキノン、 ひーリポ酸、 クロロゲ ン酸類、 カテキン類、 サポ^ン、 ムコ多糖類、 アミノ糖、 ビタミン B群、 ビ タ.ミン K、 ビタミン Ε、 コラーゲンなどが挙げられる。 さらに抗酸化作用を 有するヘスペリジン、 ケルセチン、 ルチンまたはこれらの誘導体なども好適 に用いられ得る。  Among the above functional components, components such as vitamins and dietary fiber, components that enhance blood sugar level, blood lipids, and lipid metabolism, components that have a blood pressure rise suppressing effect, antithrombotic effects, anti-inflammatory effects, A component having an effect of preventing a disease disease closely related to a cell adhesion factor such as a tumor action can be suitably contained. Such components include, for example, sulfur-containing organic compounds, ubiquinone, heripoic acid, chlorogenic acids, catechins, sapones, mucopolysaccharides, amino sugars, vitamins B, vitamin K, vitamins Ε, collagen and the like. Further, hesperidin, quercetin, rutin or derivatives thereof having an antioxidant effect can also be suitably used.
特に、 松榭皮抽出物以外の体脂肪低減剤として、 クロロゲン酸類、 力テキ ン類、 α -リポ酸、 ュビキノンおよびこれらを含む抽出物を含有させると、 優れた体脂肪の蓄積抑制または低減効果を得ることも可能である。  In particular, when chlorogenic acids, power technics, α-lipoic acid, ubiquinone, and extracts containing these are contained as body fat reducing agents other than pine husk extract, excellent body fat accumulation-suppressing or reducing effects It is also possible to get
また、 本発明の体脂肪蓄積抑制剤または体脂肪低減剤を経口摂取しゃすレ、 ようにするために、 添加剤としては、 賦形剤、 増量剤、 結合剤、 増粘剤、 乳 ィ匕剤、 滑沢剤、 湿潤剤、 懸濁剤、 着色料、 香料、 食品添加物などを添加し得 る。 ( I V) 体脂肪蓄積抑制剤または体脂肪低減剤 . 本発明の体脂肪蓄積抑制剤または体脂肪低減剤は、 上記松榭皮抽出物と大 豆ペプチドとを含有し、 必要に応じてその他の機能性成分、 栄養成分、 添加 剤などを含有し得る。 具体的には、 これらの成分を用いて、 通常、 当業者が 行う加工を施し、 各種の形状に調製される。 In addition, in order to orally ingest the body fat accumulation inhibitor or body fat reducing agent of the present invention, additives include excipients, bulking agents, binders, thickeners, and milking agents. , Lubricating agents, wetting agents, suspending agents, coloring agents, fragrances, food additives and the like can be added. (IV) Body fat accumulation inhibitor or body fat reducing agent. The body fat accumulation inhibitor or body fat reducing agent of the present invention contains the above pine peel extract and soybean peptide, and optionally contains other soybean peptides. It may contain functional ingredients, nutritional ingredients, additives and the like. Specifically, using these components, processing usually performed by those skilled in the art is performed to prepare various shapes.
例えば、 本発明の体脂肪蓄積抑制剤または体脂肪低減剤の加工方法は、 例 えば、 松樹皮抽出物および大豆ペプチドに賦形剤などを加えて、 錠剤、 丸剤 などの形状に成形する方法、 成形せずに散剤の形態およびその他の形態とす る方法などが挙げられる。 その他の剤型としては、 ハードカプセル、 ソフト カプセルなどのカプセル剤、 粉末剤、 顆粒剤、 液剤、 ペーストなどがある。 また、 ティーバッグ状、 飴状などに加工することも可能である。  For example, the processing method of the body fat accumulation inhibitor or the body fat reducing agent of the present invention is, for example, a method of adding excipients to a pine bark extract and a soy peptide to form a tablet, a pill or the like. Examples thereof include a method of forming a powder and other forms without molding. Other dosage forms include capsules such as hard capsules and soft capsules, powders, granules, liquids, and pastes. It can also be processed into tea bags, candy, etc.
本発明の体脂肪蓄積抑制剤または体脂肪低減剤の摂取方法は、 特に限定さ れない。 体脂肪蓄積抑制剤または体脂肪低減剤を、 その形状または好みに応 じて、 そのまま飲食しても良いし、 あるいは水、 湯、 牛乳などに溶いて飲ん でも良いし、 成分を浸出させたものを飲んでも良い。  The method of ingesting the body fat accumulation inhibitor or body fat reducing agent of the present invention is not particularly limited. The body fat accumulation inhibitor or body fat reducing agent may be eaten or consumed as it is, or may be dissolved in water, hot water, milk, etc., depending on its shape or preference, or may be leached from its ingredients You may drink.
また、 本発明の体脂肪蓄積抑制剤または体脂肪低減剤は、 一般的に、 松樹 皮抽出物を体脂肪蓄積抑制剤または体脂肪低減剤中に 0 . 0 0 0 1質量%〜 5 0質量%の割合で含有することが好ましい。  In addition, the body fat accumulation inhibitor or body fat reducing agent of the present invention generally contains pine bark extract in a body fat accumulation inhibitor or a body fat reducing agent in an amount of 0.0001 to 50% by mass. % Is preferably contained.
また、 本発明の体脂肪蓄積抑制剤または体脂肪低減剤の摂取量は、 その効 果を得るために、 1日あたりの摂取量が松樹皮抽出物としての下限値で 0 . 0 0 1 g以上、 好ましくは 0 . 0 0 2 g以上、 より好ましくは 0 . 0 2 g以 上、 最も好ましくは 0 . 0 4 g以上である。 また、 1日あたりの摂取量は、 プロアントシァニジンとしての上限値で 2 . 0 g以下、 好ましくは 1 . 0 g 以下、 より好ましくは 0 . 6 g以下である。  In order to obtain the effect, the amount of the body fat accumulation inhibitor or body fat reducing agent of the present invention is set to 0.001 g per day as the lower limit of the pine bark extract. As described above, the weight is preferably 0.02 g or more, more preferably 0.02 g or more, and most preferably 0.04 g or more. In addition, the daily intake is 2.0 g or less, preferably 1.0 g or less, more preferably 0.6 g or less as the upper limit of proanthocyanidins.
さらに、 本発明の体脂肪蓄積抑制剤または体脂肪低減剤に使用される大豆 ペプチドの配合量は特に制限はないが、 松樹皮抽出物の乾燥質量 1 0 0質量 部に対し、 1質量部〜 2 0 0 0 0質量部が好ましく、 1 0質量部〜 1 0 0 0 0質量部がより好ましく、 1 0 0質量部〜 1 0 0 0 0質量部がさらに好まし い。 Furthermore, soybean used for the body fat accumulation inhibitor or body fat reducing agent of the present invention Although the amount of the peptide is not particularly limited, it is preferably 1 part by mass to 2000 parts by mass, and more preferably 10 parts by mass to 100 parts by mass with respect to 100 parts by mass of the dry weight of the pine bark extract. The parts by mass are more preferable, and the parts by mass of 100 to 100 parts by mass are more preferable.
(V) 本発明の食品 (V) Food of the present invention
本発明の食品は、 松樹皮抽出物と大豆ペプチドとを含有する。 松樹皮抽出 物は、 特有の風味、 例えば、 松樹皮抽出物中に含有する成分に由来する苦味 および渋味だけでなく樹皮特有のえぐみを有している。 し力 し、 大豆べプチ ドを配合することによって、 松樹皮特有の風味をマスキングし、 優れた嗜好 性を有することになる。 このため、 松樹皮抽出物を食品中により配合しやす くなり、 様々な剤形への適用が可能となる。 なお、 このようなマスキング効 果を得るための松樹皮抽出物に対する大豆ペプチドの配合量は特に制限はな いが、 好ましくは、 松樹皮抽出物 1 0 0質量部 (乾燥質量) に対し、 大豆べ プチドを 1 0 0質量部 (乾燥質量) 以上となるように配合することが好まし レ、。  The food of the present invention contains a pine bark extract and a soy peptide. The pine bark extract has a unique flavor, for example, bitterness and astringency derived from components contained in the pine bark extract, as well as bark-specific astringency. By blending soy beptide, the flavor unique to pine bark is masked and has excellent palatability. This makes it easier to incorporate the pine bark extract into foods and makes it possible to apply it to various dosage forms. The amount of the soybean peptide in the pine bark extract for obtaining such a masking effect is not particularly limited, but is preferably 100 parts by mass (dry mass) of the pine bark extract. It is preferable to add the peptide in an amount of 100 parts by mass (dry mass) or more.
さらに、 松樹皮抽出物と大豆ペプチドとを組み合わせることにより、 松樹 皮抽出物を単独で使用した場合と比較して、 松樹皮抽出物の使用量が少量で も、 より優れた体脂肪蓄積効果、 脂質吸収抑制効果などが得られる。  Furthermore, by combining the pine bark extract with the soy peptide, even when the amount of the pine bark extract used is small, a superior body fat accumulation effect can be obtained as compared with the case where the pine bark extract is used alone. An effect of suppressing lipid absorption is obtained.
実施例 Example
以下、 本発明の実施例について説明する。 なお、 本発明は、 下記の実施例' に限定して解釈すべきではなく、 特許請求の範囲における記載の範囲内で 種々の変更が可能である。  Hereinafter, examples of the present invention will be described. It should be noted that the present invention should not be construed as being limited to the following Examples, and various modifications can be made within the scope of the claims.
(参考例 1 ) 脂肪蓄積抑制作用およぴ脂質吸収抑制作用の評価 プロアントシァニジンを 6 0質量%の割合で含有する松樹皮抽出物 (O P C含有量 3 0質量。/。;株式会社東洋新薬) を用いて下記のように内臓脂肪、 皮下脂肪の脂肪蓄積抑制作用、 およぴ脂質吸収抑制作用を評価した。 (Reference Example 1) Evaluation of fat accumulation inhibitory action and lipid absorption inhibitory action Inhibition of fat accumulation in visceral fat and subcutaneous fat using pine bark extract (OPC content 30 mass./ .; Toyo Shinyaku Co., Ltd.) containing proanthocyanidin at a ratio of 60% by mass as follows: The effect and the effect of suppressing lipid absorption were evaluated.
7週齢の雌性 I C R系マウス (日本クレア株式会社) 1 4匹を基本飼料 (MF飼料、 オリエンタル酵母工業株式会社) で 1週間馴化した。 次いで、 各群の平均体重がほぼ同等となるように 2群に分けた。 次いで、 1群のマウ スに、 牛脂を 4 0質量%、 グラニュー糖を 9質量。/。、 および上記の松樹皮抽 出物を 5質量%含有する試験飼料を自由摂取させた (試験群とする) 。 残り の 1群のマウスには、 試験飼料と同様であるが松樹皮抽出物のみを含有しな い対照飼料を自由摂取させた (対照群とする) 。  Fourteen 7-week-old female ICR mice (CLEA Japan, Inc.) were acclimated to a basic diet (MF diet, Oriental Yeast Co., Ltd.) for 1 week. Then, each group was divided into two groups so that the average body weight was almost the same. Next, 40 mass% of tallow and 9 mass of granulated sugar were added to a group of mice. /. , And a test feed containing 5% by mass of the above pine bark extract was allowed to freely ingest (test group). The remaining one group of mice was fed a control diet similar to the test diet but without pine bark extract alone (the control group).
摂取開始から 2 5日目に各ラットの体重を測定し、 体重の増加率を、 下記 の式 (I ) で算出した。 増加率 (%) = (摂取開始 25曰目の体重一摂取前の体重)ノ摂取前の体重 X 1 00 ■■■ (I)  On the 25th day from the start of ingestion, the weight of each rat was measured, and the rate of weight gain was calculated by the following formula (I). Rate of increase (%) = (weight of body weight before ingestion 25-body weight before ingestion) weight before ingestion X 1 00 ■ 1 (I)
また、 皮下脂肪を実験動物用 X線 C T (商品名 : L A T h e a t a ;ァロ 力社) で測定した。 次いで、 後腹膜脂肪およぴ子宫周囲脂肪を摘出して、 こ れらの脂肪の合計質量'(内臓脂肪の質量) を測定した。 さらに、 各マウスの 眼底より採血した血液は、 血中の中性脂肪値を中性脂肪測定キット (和光純 薬工業株式会社) で測定した。 結果を表 1に示す。 The subcutaneous fat was measured by X-ray CT for laboratory animals (trade name: LAT heata; Aro Rikisha). Then, retroperitoneal fat and peripheral fat were excised, and the total mass of these fats (mass of visceral fat) was measured. Further, the blood collected from the fundus of each mouse was used to measure the triglyceride level in the blood using a triglyceride measurement kit (Wako Pure Chemical Industries, Ltd.). Table 1 shows the results.
表 1 table 1
Figure imgf000014_0001
Figure imgf000014_0001
* : p<0. 05で有意差有  *: significant difference at p <0.05
表 1の結果より、 松樹皮抽出物を含有する試験飼料は、 内臓脂肪および皮 下脂肪量が減少し、 そして体重の減少効果を有することがわかつた。 From the results in Table 1, it was found that the test feed containing the pine bark extract reduced the amount of visceral fat and subcutaneous fat, and had an effect of reducing body weight.
(実施例 1 ) 脂肪蓄積抑制作用および脂質吸収抑制作用の評価 (Example 1) Evaluation of fat accumulation inhibitory action and lipid absorption inhibitory action
プロアントシァニジンを 6 0質量%の割合で含有する松樹皮抽出物 (O P C含有量 3 0質量%;株式会社東洋新薬) を用いて下記のように内臓脂肪お よぴ皮下脂肪の脂肪蓄積抑制作用を評価した。  Inhibition of fat accumulation in visceral fat and subcutaneous fat using pine bark extract (OPC content: 30% by mass; Toyo Shinyaku Co., Ltd.) containing proanthocyanidin at a ratio of 60% by mass as follows: The effect was evaluated.
7週齢の雌性 I C R系マウス (日本クレア株式会社) 1 5匹を基本飼料 (MF飼料、 オリエ 'ンタル酵母工業株式会社) で 1週間馴化した。 次いで、 各群の平均体重がほぼ同等となるように 3群に分けた。 次いで、 1群のマウ スに、 牛脂を 4 Ό質量%、 グラニュー糖を 9質量%、 上記の松樹皮抽出物を 2質量%、 および大豆ペプチド (不二製油株式会社) を 5質量%含有する試 験飼料 1を自由摂取させた (試験群 1とする) 。 もう 1群には、 試験飼料 1 の松樹皮抽出物を含有しなかったこと以外は、 試験飼料 1と同様にして調製 した比較飼料 1を自由摂取させた (比較群 1とする) 。 残りの群は、 試験飼 料 1の松樹皮抽出物および大豆べプチドを含有しなかったこと以外は、 試験 飼料 1と同様にして調製した比較飼料 2を自由摂取させた (比較群 2とす る) 。 Fifteen 7-week-old female ICR mice (CLEA Japan) were acclimated to a basic diet (MF diet, Oriental Yeast Co., Ltd.) for 1 week. Then, each group was divided into three groups so that the average body weight was almost the same. Next, one group of mice contains 4% by mass of beef tallow, 9% by mass of granulated sugar, 2% by mass of the above pine bark extract, and 5% by mass of soybean peptide (Fuji Oil Co., Ltd.) The test feed 1 was freely taken (referred to as test group 1). The other group was allowed to freely ingest comparative diet 1 prepared in the same manner as trial diet 1 except that it did not contain the pine bark extract of trial diet 1 (comparative group 1). The remaining groups were allowed free access to comparative feed 2 prepared in the same manner as test feed 1 except that they did not contain the pine bark extract and soy beptide of test feed 1 (comparison group 2). ).
摂取開始から 2 5日目に各ラットの体重を測定し、 参考例 1と同様の方法 で体重増加率を算出し、 そして参考例 1と同様の方法で、 内臓脂肪および皮 下脂肪の質量を測定した。 結果を表 2に示す。 表 2 On the 25th day from the start of ingestion, the weight of each rat was measured, the weight gain was calculated in the same manner as in Reference Example 1, and the mass of visceral fat and subcutaneous fat was determined in the same manner as in Reference Example 1. It was measured. Table 2 shows the results. Table 2
Figure imgf000015_0001
Figure imgf000015_0001
値は平均値土標準偏差  The values are the mean soil standard deviation
表 2の結果より、 松樹皮抽出物と大豆べプチドとを含有する試験飼料 1は、 大豆べプチドのみを含有する比較飼料 1およぴ松樹皮抽出物および大豆ぺプ チドを含有しない比較飼料 2に比べて、 優れた体脂肪の蓄積抑制または低減 効果を有することが分かった。 Based on the results in Table 2, the test feed containing pine bark extract and soybean peptide 1 was the comparative feed containing only soybean peptide and the comparative feed containing no pine bark extract and soybean peptide. It was found to have an excellent effect of suppressing or reducing the accumulation of body fat as compared to 2.
さらに、 本発明の体脂肪蓄積抑制剤または体脂肪低減剤は、 松樹皮抽出物 の含有量が少量でも、 大豆べプチドと組み合わせることで、 参考例 1の松榭 皮抽出物のみを含有する試験飼料と同等の効果を発揮し得ることがわかった。  Furthermore, the body fat accumulation inhibitor or the body fat reducing agent of the present invention can be used in combination with soy beptide, even when the pine bark extract content is small, to contain only the pine bark extract of Reference Example 1. It was found that the same effect as the feed could be exerted.
(実施例 2 ) 嗜好性の評価 (Example 2) Evaluation of palatability
実施例 1で使用した松樹皮抽出物、 大豆ぺプチドおよび大豆タンパク質 (不二製油株式会社) を用いて、 表 3に記載の配合量で混合粉末の食品を製 造した。 Pine bark extract, soy peptide and soy protein used in Example 1 (Fuji Oil Co., Ltd.) was used to produce a mixed powder food in the amounts shown in Table 3.
次いで、 5人の女性パネラーに各食品 1 gをそのまま摂取してもらい、 嗜 好性に関する評価を以下の基準で評価してもらい、 平均点を算出した。 結果 を表 3に合わせて示す。  Next, 5 female panelists ingested 1 g of each food as they were, and evaluated the preference on the following criteria, and calculated the average score. The results are shown in Table 3.
0点:松樹皮抽出物特有の風味 (苦味、 渋味、 えぐみ) を強く感じる。 0 points: Feel the flavor (bitterness, astringency, and astringency) peculiar to pine bark extract.
1点:松樹皮抽出物特有の風味が感じられる。 1 point: The unique flavor of pine bark extract is felt.
2点:松樹皮抽出物特有の風味がほとんど感じられない。 表 3  2 points: The flavor peculiar to the pine bark extract is hardly felt. Table 3
Figure imgf000016_0001
Figure imgf000016_0001
表 3の結果から、 本発明の松樹皮抽出物と大豆べプチドを含有する食品は、 松樹皮特有の風味が軽減され、 優れた嗜好性を有する食品であることが分か る。 なお、 松樹皮抽出物と同量以上の大豆ペプチドを含有させることで、 よ り優れた嗜好性を有するようになることが分かる。 産業上の利用可能性 本発明によれば、 松樹皮抽出物と大豆べプチドとを含有する体脂肪の蓄積 または抑制剤は、 優れた体脂肪の蓄積抑制効果および低減効果を得ることが できる。 特に、 松樹皮抽出物中の O P Cは体内に吸収されやすく、 体内にお いて、 コレステロールの排泄、 および中性脂肪の分解を促進し、 効率よく脂 肪を代謝させる作用があると考えられ、 この松樹皮抽出物の作用と大豆ぺプ チドとの組合せにより優れた効果が得られる。 From the results in Table 3, it can be seen that the food containing the pine bark extract and soy beptide of the present invention is a food in which the flavor peculiar to pine bark is reduced and has excellent palatability. In addition, it can be seen that by including soybean peptide in the same amount or more as the pine bark extract, it becomes possible to have more excellent palatability. Industrial applicability ADVANTAGE OF THE INVENTION According to this invention, the accumulation | storage or inhibitor of body fat containing a pine bark extract and a soy beptide can obtain the excellent accumulation | storage inhibitory effect and reduction effect of body fat. In particular, OPC in the pine bark extract is easily absorbed into the body, promotes the excretion of cholesterol and the breakdown of neutral fats in the body, and is thought to have the effect of efficiently metabolizing fats. Excellent effects can be obtained by combining the action of the pine bark extract with the soybean peptide.
また、 松樹皮抽出物と大豆ペプチドとの組合せは、 松樹皮抽出物が有する 特有の風味を低減し、 嗜好性に優れた食品となる。  In addition, the combination of the pine bark extract and the soy peptide reduces the peculiar flavor of the pine bark extract and makes the food excellent in palatability.

Claims

請求の範囲 The scope of the claims
1 . 松樹皮抽出物と大豆べプチドを含有する体脂肪蓄積抑制剤または体脂肪 低減剤 1. Body fat accumulation inhibitor or body fat reducer containing pine bark extract and soy beptide
2 . 松樹皮抽出物と大豆べプチドを含有する食品。 2. Food containing pine bark extract and soy beptide.
PCT/JP2005/006540 2004-05-10 2005-03-28 Food containing extract from bark of pine WO2005107783A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004-140142 2004-05-10
JP2004140142 2004-05-10
JP2004-174396 2004-06-11
JP2004174396 2004-06-11

Publications (1)

Publication Number Publication Date
WO2005107783A1 true WO2005107783A1 (en) 2005-11-17

Family

ID=35320038

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2005/006540 WO2005107783A1 (en) 2004-05-10 2005-03-28 Food containing extract from bark of pine
PCT/JP2005/006541 WO2005107778A1 (en) 2004-05-10 2005-03-28 Body fat reducing preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/006541 WO2005107778A1 (en) 2004-05-10 2005-03-28 Body fat reducing preparation

Country Status (1)

Country Link
WO (2) WO2005107783A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10262571A (en) * 1997-03-21 1998-10-06 Kikkoman Corp Feed for animal
JPH1175708A (en) * 1997-07-15 1999-03-23 Kikkoman Corp Protein food
JP2000300190A (en) * 1999-04-26 2000-10-31 Fuji Oil Co Ltd Food and drink with reduced bitterness
JP2002020312A (en) * 2000-07-10 2002-01-23 Meiji Seika Kaisha Ltd Food composition for promoting reduction in body fat and promoter for reduction in body fat
JP2002275076A (en) * 2001-03-15 2002-09-25 Toyo Shinyaku:Kk Inhibitor of elevation of glycemia and healthy food
JP2003146898A (en) * 2001-11-09 2003-05-21 Toyo Shinyaku:Kk Hyperlipemia-improving agent
JP2003238428A (en) * 2002-02-18 2003-08-27 Toyo Shinyaku:Kk Cold-constitution curing agent and health food
JP2004242663A (en) * 2002-12-20 2004-09-02 Toyo Shinyaku:Kk Diet food

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09291039A (en) * 1995-12-26 1997-11-11 Suntory Ltd Antiobestic medicine comprising procyanidin as active ingredient
US20040077556A1 (en) * 2002-04-22 2004-04-22 Robert Chinery Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
JP2005047839A (en) * 2003-07-31 2005-02-24 Toyo Shinyaku:Kk Proanthocyanidin-containing composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10262571A (en) * 1997-03-21 1998-10-06 Kikkoman Corp Feed for animal
JPH1175708A (en) * 1997-07-15 1999-03-23 Kikkoman Corp Protein food
JP2000300190A (en) * 1999-04-26 2000-10-31 Fuji Oil Co Ltd Food and drink with reduced bitterness
JP2002020312A (en) * 2000-07-10 2002-01-23 Meiji Seika Kaisha Ltd Food composition for promoting reduction in body fat and promoter for reduction in body fat
JP2002275076A (en) * 2001-03-15 2002-09-25 Toyo Shinyaku:Kk Inhibitor of elevation of glycemia and healthy food
JP2003146898A (en) * 2001-11-09 2003-05-21 Toyo Shinyaku:Kk Hyperlipemia-improving agent
JP2003238428A (en) * 2002-02-18 2003-08-27 Toyo Shinyaku:Kk Cold-constitution curing agent and health food
JP2004242663A (en) * 2002-12-20 2004-09-02 Toyo Shinyaku:Kk Diet food

Also Published As

Publication number Publication date
WO2005107778A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
JP2006045212A (en) Oral composition containing specific quinic acid derivative
JP2003325135A (en) Health food
JP2004123707A (en) Blood circulation-ameliorating composition
JP4879741B2 (en) Body fat reducing agent
JP2003146898A (en) Hyperlipemia-improving agent
JP2008214191A (en) Agent for suppressing accumulation of lipid in liver
JP2005097273A (en) Athletic ability-enhancing composition
JP2010159283A (en) Proanthocyanidin-containing composition
JP4352030B2 (en) healthy food
JP3860133B2 (en) Diet food
JP2006104182A (en) Composition for reducing body fat
JP2005097324A (en) Health food and health beverage
JP2006290876A (en) Anti-diabetic agent
JP2004049135A (en) Health food
JP3130327B2 (en) Liver dysfunction preventive agent and functional food having hepatic dysfunction preventive action
JP2003325136A (en) Arthritis-improving food
JP2005170836A (en) Marine alga extract and lipase inhibitor containing the same
JP2005047839A (en) Proanthocyanidin-containing composition
JP2005047818A (en) Health food and health drink
JP2005278654A (en) Arthritis-improving food
JP2003095965A (en) Hypertension-preventing and treating medicine
JP4400712B2 (en) Antioxidant enhancement food
JP2005060338A (en) Proanthocyanidin-including composition
JP2006022082A (en) Lipid metabolism improver
JP2005013208A (en) Healthy food and healthy drink

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP